This cohort study investigates the safety and effectiveness of the standardized PERIXa protocol for perioperative discontinuation of factor Xa inhibitors among patients with atrial fibrillation undergoing procedures with minimal or low bleeding risk. Here, F10 is linked to atrial fibrillation.